-
10:36:10 AM

INVVY Stock News

06/02/23 12:11 PM
OTC : INVVY
Indivior Reaches Agreement with States' Attorneys General and District of Columbia to Resolve Antitrust Multi-District Litigation Claims
Indivior PLC, a leading addiction treatment company, announced that its subsidiary, Indivior Inc., has reached an agreement to resolve the claims brought by the Attorneys General of 41 states and the District of Columbia in the In re Suboxone Antitrust Litigation multi-district litigation. The settlement amount is in line...
RHEA-AI
neutral
05/23/23 12:53 PM
OTC, Nasdaq : INVVY
Indivior PLC Form 20-F Registration Statement for Additional US Listing Now Available; Trading on NASDAQ Expected to Commence on June 12th
Indivior PLC today announced that its registration statement on Form 20- F required for the additional U.S. listing of its ordinary shares is now available at www.sec.gov and under the "Investors" section of the Company's website. Trading in Indivior's ordinary shares on the NASDAQ Global Select Market is expected to...
RHEA-AI
neutral
05/22/23 7:40 PM
OTC : INVVY
fda approval
Indivior Announces U.S. Food and Drug Administration Approval of OPVEE® (nalmefene) Nasal Spray, An Opioid Overdose Rescue Medicine for Natural and Synthetic Opioids Like Fentanyl
In the 12- month period ending in December 2022, over 79,000 people in the U.S. were reported to have died of an opioid overdose, of which 90%– approximately 72,000– were linked to illicit synthetic opioids, mainly fentanyl 1. Approval based on data from a pharmacodynamic study demonstrating that OPVEE provides fast onset of reversal of respiratory depression...
RHEA-AI
neutral